MSD (Merck Sharp and Dohme) announced findings from the GO-AHEAD study1 showing that patients with active non-radiographic axial spondyloarthritis (nr-AxSpA) treated with injections of Simponi® (golimumab) 50 mg every four weeks for 16 weeks had significantly greater improvements in disease activit
radiographic הגייה עם משמעויות, מילים נרדפות, הפכים, תרגומים, משפטים ועוד